Nimodipine for primary degenerative, mixed and vascular dementia-Reference-Cited by-同舟云学术

Nimodipine for primary degenerative, mixed and vascular dementia

Published:2002-07-22 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Birks Jacqueline¹,López-Arrieta Jess²

Affiliation:

1. University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford UK OX2 6UD

2. Hospital Universitario La Paz-Cantoblanco; Geriatric Department; Ctra de Colmenar km 14,500 Madrid Spain 28049

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD000147/fullpdf

Reference75 articles.

1. Nimodipine in the treatment of old age dementias;Ban;Progress in Neuro-Psychopharmacology and Biological Psychiatry,1990

2. Calcium antagonists and multi-infarct dementia: A trial involving sequential NMR and psychometric assessment;Besson;International Journal of Geriatric Psychiatry,1988

3. Bono G Sinforiani E Trucco M Cavallini A Acuto GC Nappi G Nimodipine in cCVD patients:clinical and neuropsychological results of a double-blind cross-over study Nimodipine. Pharmacological and clinical properties. Proceedings of the 1st International Nimotop Symposium, Munich 1984 Schattauer Verlag 1984 275 87

4. Nimodipine in the treatment of Alzheimer's disease;Baumel,1989

5. Palliation of the progressive memory impairment of Alzheimer's disease by nimodipine;Branconnier;Psychopharmacology,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nimodipine Protects Vascular and Cognitive Function in an Animal Model of Cerebral Small Vessel Disease;Stroke;2024-07

2. Abnormal grey matter structural changes in patients with end-stage kidney disease and mild cognitive impairment: correlations with clinical features;Metabolic Brain Disease;2023-09-30

3. RAGE: a potential target for Epimedium’s anti-neuroinflammation role in vascular dementia—insights from network pharmacology and molecular simulation;Journal of Biomolecular Structure and Dynamics;2023-09-21

4. The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review;Frontiers in Pharmacology;2023-08-24

5. Abnormal grey matter structural changes in patients with end-stage kidney disease and mild cognitive impairment: correlations with clinical features;2023-05-24